ClinicalTrials.Veeva

Menu

the Pathophysiology of the Onset of Atrial Fibrillation in Obstructive Sleep Apnea (PARABOLA)

Catharina Hospital logo

Catharina Hospital

Status

Invitation-only

Conditions

Obstructive Sleep Apnea of Adult
Atrial Fibrillation

Treatments

Diagnostic Test: Polysomnography

Study type

Observational

Funder types

Other

Identifiers

NCT06246825
CatharinaZE_PARABOLA

Details and patient eligibility

About

Rationale: Obstructive sleep apnea (OSA) is a highly prevalent, often undiagnosed, modifiable risk factor for atrial fibrillation (AF), as well as AF-related complications and treatment effectiveness. It is unclear which OSA-related pathophysiological mechanism, i.e. intrathoracic pressure shifts, hypoxemia or sympathovagal imbalance, plays the most dominant role, and a better understanding of these mechanisms could provide valuable information in future diagnostic and therapeutic strategies in this population. Objective: The primary objective is to assess the role of OSA-related pathophysiological mechanisms in the initiation of AF by a multi-parametric strategy that combines the estimated parameters. The main hypothesis is that intrathoracic pressure fluctuations are the predominant mechanism. The secondary objective is to validate a nonobtrusive sensing technology based on photoplethysmography (PPG) and diaphragm electromyography (dEMG) measurements as surrogates for gold standard technology based on invasive intraoesophageal pressure (PES) measurement. Study population: Adult patients with paroxysmal AF with nocturnal onset and high risk of OSA based on the STOP-BANG questionnaire. Study design: An observational study in a selected cohort. Subjects are recruited from the AF outpatient clinic of the Catharina Hospital, and referred to Kempenhaeghe Centre for Sleep Medicine for a one-night full PSG, with the addition of dEMG and PPG. The acquired data will be analysed at the Eindhoven Technical University. Main study parameters/endpoints: Primary endpoint: Identification of prognostic factors for the initiation of AF in relation to OSA-related pathophysiological mechanisms..nl

Enrollment

190 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Paroxysmal or persistent AF

AND

  • STOP-BANG score >5 or STOP-BANG >4 and typical nocturnal onset of AF
  • A positive WATCH-PAT screening
  • very high clinical suspicion of OSA, with STOP-BANG score >3

Exclusion criteria

  • current adequate treatment of OSA
  • Reversible cause of AF
  • severe lung disease (COPD Gold IV, pumonary fibrosis, lobectomy) wever esophageal disease (malignancy, stricture, esophagectomy)

Trial design

190 participants in 1 patient group

PARABOLA cohort
Description:
Patients with paroxysmal or persistent atrial fibrillation and a high likelihood of obstructive sleep apnea
Treatment:
Diagnostic Test: Polysomnography

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems